News

Article

Pharmaceutical Technology

Pharmaceutical Technology, Trends in Formulation, October 2022
Volume2022 eBook
Issue 3
Pages: 4–9

Using a Drug Candidate Screening Strategy to Mitigate Late-Stage Risk

Author(s):

An early drug candidate screening strategy should incorporate clear targets to lessen late-stage failure.

Kalyakan/Stock.adobe.com – optimizing early drug candidate screening can save time and shorten drug discovery and development timelines.

Kalyakan/Stock.adobe.com

Time-to-market remains a significant factor in drug development today, as delays in timelines can often have costly and damaging effects, not only to the drug developer but to the patient. Challenges in the drug development cycle arise early in the drug candidate screening process. In this article, Industry players discuss how technological innovation and advances in analytical approaches enhance early drug candidate screening workflows to help shorten drug discovery and development timelines.

Read this article in Pharmaceutical Technology’s October 2022 Trends in Formulation eBook.

About the author

Feliza Mirasol is science editor for Pharmaceutical Technology.

Article Details

Pharmaceutical Technology
eBook: Trends in Formulation, October 2022
October 2022
Pages: 4–9

Citation

When referring to this article, please cite it as F. Mirasol, “Using a Drug Candidate Screening Strategy to Mitigate Late-Stage Risk," Pharmaceutical Technology Trends in Formulation eBook (October 2022).

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content